标题
Bortezomib Dendrimer Prodrug-Based Nanoparticle System
作者
关键词
-
出版物
ADVANCED FUNCTIONAL MATERIALS
Volume -, Issue -, Pages 1807941
出版商
Wiley
发表日期
2019-02-11
DOI
10.1002/adfm.201807941
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combined Effect of Bortezomib and Menadione Sodium Bisulfite on Proteasomes of Tumor Cells: The Dramatic Decrease of Bortezomib Toxicity in a Preclinical Trial
- (2018) Tatiana Astakhova et al. Cancers
- Bortezomib-based chemotherapy in mantle cell lymphoma
- (2018) Simon Rule LANCET ONCOLOGY
- Adverse Event Reporting in Clinical Trials: Time to Include Duration as Well as Severity
- (2017) Oliver Sartor ONCOLOGIST
- MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma
- (2016) Y.-W. Qiang et al. BLOOD
- Molecular Mechanisms of the Cardiotoxicity of the Proteasomal-Targeted Drugs Bortezomib and Carfilzomib
- (2016) Brian B. Hasinoff et al. Cardiovascular Toxicology
- Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessment
- (2015) Moshe E. Gatt et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Behavioral and pharmacological characteristics of bortezomib-induced peripheral neuropathy in rats
- (2015) Shota Yamamoto et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- In Vitro and In Vivo Antitumor Activity of a Novel Alkylating Agent, Melphalan-Flufenamide, against Multiple Myeloma Cells
- (2013) D. Chauhan et al. CLINICAL CANCER RESEARCH
- Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d’Etude des Lymphomes de l’Adulte (GELA)
- (2012) Vincent Ribrag et al. EUROPEAN JOURNAL OF CANCER
- Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study
- (2011) Ticiana B. Leal et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients
- (2011) S. L. Corthals et al. HAEMATOLOGICA
- Bortezomib in patients with renal impairment
- (2011) Isik Kaygusuz et al. Hematology
- Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib
- (2010) Dominika Nowis et al. AMERICAN JOURNAL OF PATHOLOGY
- Acute Dyspnea From Treatment of AL Amyloidisis With Bortezomib
- (2010) Abhimanyu Ghose et al. AMERICAN JOURNAL OF THERAPEUTICS
- Time to Treatment Response in Patients with Follicular Lymphoma Treated with Bortezomib Is Longer Compared with Other Histologic Subtypes
- (2010) O. A. O'Connor et al. CLINICAL CANCER RESEARCH
- Bortezomib
- (2009) Monique P. Curran et al. DRUGS
- Aminopeptidase inhibition as a targeted treatment strategy in myeloma
- (2009) H. E. Moore et al. MOLECULAR CANCER THERAPEUTICS
- Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib
- (2008) F.-T. Liu et al. BLOOD
- Bortezomib-Induced Skin Eruption
- (2008) S. Sanchez-Politta et al. DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now